Ed Apap

Description

No description information is available for the specified drug.

Uses and Indications

This drug is indicated for the reduction of fever and the relief of minor aches and pains associated with various conditions, including the common cold, influenza, headaches, sore throat, immunizations, and toothache.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

Shake the formulation well before use. Healthcare professionals should determine the appropriate dosage based on the patient's weight, utilizing the dosage chart provided below. If weight is not available, age may be used as a secondary guide for dosing.

Dosing may be repeated every 4 hours as necessary; however, it is imperative not to exceed 5 doses within a 24-hour period. Continuous use beyond 5 days should only occur under the guidance of a physician.

Dosage Chart:

• For patients weighing under 24 lbs. (under 2 years): Consult a physician for appropriate dosing.

• For patients weighing 24-35 lbs. (2-3 years): Administer 1 teaspoon (5 mL).

• For patients weighing 36-47 lbs. (4-5 years): Administer 1 ½ teaspoons (7.5 mL).

• For patients weighing 48-59 lbs. (6-8 years): Administer 2 teaspoons (10 mL).

• For patients weighing 60-71 lbs. (9-10 years): Administer 2 ½ teaspoons (12.5 mL).

• For patients weighing 72-95 lbs. (11 years): Administer 3 teaspoons (15 mL).

Contraindications

Use of this product is contraindicated in the following situations:

Co-administration with any other drug containing acetaminophen, whether prescription or non-prescription, is prohibited. If there is uncertainty regarding the presence of acetaminophen in a medication, consultation with a healthcare professional is advised.

This product should not be used in children with a known allergy to acetaminophen or any of the inactive ingredients contained in the formulation.

Additionally, it is essential to adhere to the recommended dosage, as exceeding this may lead to overdose, which poses significant health risks.

Warnings and Precautions

This product contains acetaminophen, which poses a risk of severe liver damage if the recommended dosage is exceeded. Specifically, healthcare professionals should advise caregivers that no more than 5 doses should be administered within a 24-hour period, as this represents the maximum daily amount. Additionally, caution should be exercised if the product is used concurrently with other medications containing acetaminophen.

In cases where a child presents with a severe sore throat that persists for more than 2 days, or is accompanied by fever, headache, rash, nausea, or vomiting, it is imperative to consult a physician promptly to rule out any serious underlying conditions.

Healthcare providers should also inquire about the child's medical history prior to recommending this product. It is particularly important to seek medical advice if the child has a history of liver disease. Furthermore, if the child is currently taking the anticoagulant warfarin, consultation with a doctor or pharmacist is advised before use to prevent potential interactions.

In the event of an overdose, immediate medical assistance should be sought, or the Poison Control Center should be contacted without delay. Rapid intervention is crucial, even if no symptoms are immediately apparent.

Caregivers should be instructed to discontinue use and consult a physician if any new symptoms arise, if there is evidence of redness or swelling, if pain worsens or persists beyond 5 days, or if fever intensifies or lasts longer than 3 days. These symptoms may indicate a serious condition requiring further evaluation.

Side Effects

Severe liver damage may occur in patients who exceed the recommended dosage of this product, which contains acetaminophen. Specifically, taking more than five doses within a 24-hour period, or using it concurrently with other medications containing acetaminophen, significantly increases the risk of liver injury.

Patients should be advised to consult a healthcare professional if they experience a severe sore throat that persists for more than two days, or if it is accompanied by fever, headache, rash, nausea, or vomiting. These symptoms may indicate a more serious condition requiring medical evaluation.

This product should not be used in conjunction with any other medications containing acetaminophen, whether prescription or non-prescription. Patients are encouraged to verify the presence of acetaminophen in other medications with a healthcare provider or pharmacist if uncertain. Additionally, individuals with known allergies to acetaminophen or any inactive ingredients in this formulation should avoid its use.

Before administering this product, it is advisable to consult a healthcare professional if the patient has liver disease or is taking the anticoagulant warfarin, as interactions may pose additional risks.

While using this product, patients must adhere strictly to the recommended dosage to prevent overdose. If new symptoms arise, or if there is any redness or swelling, or if pain worsens or persists beyond five days, medical advice should be sought. Furthermore, if fever intensifies or lasts longer than three days, it may signal a serious underlying condition that necessitates prompt medical attention.

In the event of an overdose, which may lead to liver damage, immediate medical assistance should be sought, or contact with a Poison Control Center is recommended. Quick medical intervention is crucial, even if no signs or symptoms are initially apparent.

Drug Interactions

Acetaminophen may interact with the anticoagulant warfarin. Co-administration of these agents should be approached with caution. It is advisable for patients to consult a healthcare professional, such as a doctor or pharmacist, prior to using acetaminophen if they are concurrently taking warfarin. Monitoring of coagulation parameters may be warranted to ensure therapeutic efficacy and safety.

Packaging & NDC

Below are the non-prescription pack sizes of Ed Apap (acetaminophen). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under 2 years of age should not use this medication without consulting a doctor. For children aged 2 years and older, dosing is based on weight and age as follows:

• For children under 24 lbs (under 2 years), consult a doctor.

• For those weighing 24-35 lbs (2-3 years), the recommended dose is 1 teaspoon (5 mL).

• For children weighing 36-47 lbs (4-5 years), the dose is 1 1/2 teaspoons (7.5 mL).

• For those weighing 48-59 lbs (6-8 years), the dose is 2 teaspoons (10 mL).

• For children weighing 60-71 lbs (9-10 years), the dose is 2 1/2 teaspoons (12.5 mL).

• For those weighing 72-95 lbs (11 years), the dose is 3 teaspoons (15 mL).

It is important to note that severe liver damage may occur if a child takes more than 5 doses in a 24-hour period, which is the maximum daily amount. Parents should consult a doctor before use if their child has liver disease or is taking the blood-thinning medication warfarin.

Healthcare professionals should advise parents to stop use and consult a doctor if new symptoms occur, if there is redness or swelling, if pain worsens or lasts more than 5 days, or if fever worsens or lasts more than 3 days, as these may indicate a serious condition.

An overdose may lead to liver damage; therefore, in the event of an overdose, immediate medical help should be sought or a Poison Control Center contacted, even if no signs or symptoms are present.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any potential adverse effects or changes in efficacy, given the lack of targeted data for this population.

Pregnancy

The available prescribing information does not provide specific data regarding the use of acetaminophen during pregnancy. Consequently, healthcare professionals should exercise caution when recommending this medication to pregnant patients. There are no documented safety concerns, dosage modifications, or special precautions outlined for the use of acetaminophen in this population. Given the lack of information, it is advisable for women of childbearing potential to consult with their healthcare provider before using acetaminophen during pregnancy to ensure that potential risks and benefits are adequately assessed.

Lactation

There are no specific warnings or recommendations regarding the use of this product by lactating mothers. Additionally, there are no statements concerning the potential for excretion in breast milk or any associated risks to breastfed infants.

Renal Impairment

Patients with renal impairment have no specific information regarding dosage adjustments, special monitoring, or safety considerations provided in the drug insert. Therefore, healthcare professionals should exercise caution when prescribing this medication to individuals with reduced kidney function, as the lack of data necessitates careful clinical judgment.

Hepatic Impairment

Patients with hepatic impairment should exercise caution when using this product, which contains acetaminophen. It is essential to consult a healthcare professional prior to use if the patient has a history of liver disease.

The maximum recommended dosage for this product is five doses within a 24-hour period. Exceeding this limit may lead to severe liver damage, particularly in patients with compromised liver function. Additionally, the risk of liver damage increases significantly if the patient is concurrently using other medications that contain acetaminophen.

In the event of an overdose, immediate medical attention is crucial, even if the patient does not exhibit any signs or symptoms of liver damage. Contacting a Poison Control Center or seeking emergency medical help is strongly advised to mitigate potential risks associated with acetaminophen overdose.

Overdosage

In the event of an overdose, defined as the ingestion of more than the recommended dose, there is a significant risk of liver damage. Healthcare professionals should be aware that the severity of the effects may not be immediately apparent, as symptoms can be delayed or absent initially.

It is imperative that individuals who suspect an overdose seek medical assistance promptly. Contacting a Poison Control Center or obtaining immediate medical help is crucial. Quick intervention is essential, even in the absence of noticeable signs or symptoms, to mitigate potential harm and ensure appropriate management.

Healthcare providers should remain vigilant and prepared to assess and manage the situation effectively, prioritizing the patient's safety and well-being.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep this medication out of reach of children to prevent accidental ingestion. It is important to inform patients not to use this product in conjunction with any other medications that contain acetaminophen, whether prescription or non-prescription. If patients are uncertain about the presence of acetaminophen in other medications, they should be encouraged to consult a doctor or pharmacist for clarification.

Patients should be cautioned against using this product if their child has a known allergy to acetaminophen or any of the inactive ingredients contained in the formulation. They should be instructed to discontinue use and seek medical advice if new symptoms arise, if there is any redness or swelling, or if pain worsens or persists beyond five days. Additionally, if a fever intensifies or lasts longer than three days, patients should be advised to stop use and consult a doctor, as these may indicate a serious underlying condition.

While using this product, it is crucial for patients to adhere to the recommended dosage and to be aware of the overdose warning. Healthcare providers should also recommend that patients consult a doctor prior to use if their child has liver disease. Furthermore, patients taking the blood-thinning medication warfarin should be advised to seek guidance from a doctor or pharmacist before using this product.

Storage and Handling

The product is supplied in configurations that include specific NDC numbers, which should be referenced for accurate identification. It is essential to store the product at room temperature, maintaining a range of 15° to 30° C (59° to 86° F). Care should be taken to protect the product from freezing and exposure to light to ensure its integrity and efficacy.

Additionally, it is crucial to inspect the product prior to use. The product must not be used if the printed inner cap seal is broken or missing, as this may indicate compromised safety or quality. Proper handling and storage conditions are vital for maintaining the product's effectiveness.

Additional Clinical Information

The medication is administered orally, with a recommended repeat dose every 4 hours as needed. Clinicians should advise patients not to exceed 5 doses within a 24-hour period and to limit use to a maximum of 5 days unless otherwise directed by a healthcare professional.

No additional information is available regarding laboratory tests, abuse potential, patient counseling, or postmarketing experiences.

Drug Information (PDF)

This file contains official product information for Ed Apap, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)